Purpose of this Study
We are doing this study to better understand women's preferences for and concerns about hormone replacement. We want to learn from women who have had their fallopian tubes and ovaries removed due to BRCA1 and BRCA2 mutations.
Who Can Participate?
Eligibility
Women ages 19-49 who:
- Are diagnosed with a BRCA1 or BRCA2 mutation
- Are scheduled to have a risk reducing surgery with a gynecologic oncologist
- Do not have any history of cancer
Age Range
19-49
Sex/Genders
Female (cisgender)
Transgender male
Looking for Healthy Participants
No
What is Involved?
Description
If you choose to join this study, you will fill out brief surveys at several time points before and after your surgery. You will also get a random assignment (like a coin flip) to either receive standard of care counseling about hormone replacement therapy or the standard of care plus an educational video.
Locations
Duke University Hospital
Visit Timing
Weekdays
Compensation
Yes
Spanish Materials Available
No
Study Details
Full Title
Patient centered education about hormone replacement therapy after risk reducing salpingo-oophorectomy: a pilot randomized controlled trial
Principal Investigator
Laura
Havrilesky
Protocol Number
PRO00117007
NCT ID
NCT06972719
Phase
N/A
Enrollment Status
Pending Open to Enrollment